Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any congenital stationary night blindness in which the cause of the disease is a mutation in the LRIT3 gene.
Features include always present findings: Nyctalopia, Reduced visual acuity, Congenital stationary night blindness, and High myopia; and common findings: Strabismus, Retinal perforation, and Electronegative electroretinogram.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 3 | Strabismus, Retinal perforation, Congenital stationary night blindness |
LRIT3 encodes leucine rich repeat, Ig-like and transmembrane domains 3 (679 aa). Plays a role in the synapse formation and synaptic transmission between cone photoreceptor cells and retinal bipolar cells. Highest expression in Brain Cerebellum (1.7 TPM) and Brain Cerebellar Hemisphere (1.7 TPM).
Congenital stationary night blindness 1F is associated with mutations in the LRIT3 gene on chromosome 4.
LRIT3 is classified as a druggable target with score 0.0.
Genetic testing for LRIT3 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 4 always present features, 3 common features.
No clinical trials have been registered for congenital stationary night blindness 1F.
9 publications have been identified in PubMed for congenital stationary night blindness 1F. Research spans Basic Science / Preclinical (67%), Review / Meta-Analysis (11%), and Epidemiology / Natural History (11%).
Spanic F (2026). [PMID: 41729106](https://pubmed.ncbi.nlm.nih.gov/41729106/). *Acta Ophthalmol*. [Basic Science / Preclinical]
Hasan N (2026). [PMID: 42055330](https://pubmed.ncbi.nlm.nih.gov/42055330/). *J Biol Chem*. [Basic Science / Preclinical]
Taha I (2026). [PMID: 42106701](https://pubmed.ncbi.nlm.nih.gov/42106701/). *BMC Ophthalmol*. [Review / Meta-Analysis]
Rodgers J (2025). [PMID: 39825567](https://pubmed.ncbi.nlm.nih.gov/39825567/). *Mol Ther*. [Gene Therapy / Novel Therapeutics]
Sundaramurthy S (2025). [PMID: 40551348](https://pubmed.ncbi.nlm.nih.gov/40551348/). *Acta Ophthalmol*. [Epidemiology / Natural History]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 9:41 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Pregnancy and birth |
1 |
Congenital stationary night blindness |
Zhao C (2025). [PMID: 40263339](https://pubmed.ncbi.nlm.nih.gov/40263339/). *Nat Commun*. [Basic Science / Preclinical]
Hasan N (2025). [PMID: 40766553](https://pubmed.ncbi.nlm.nih.gov/40766553/). *bioRxiv*. [Basic Science / Preclinical]
Wilmet B (2024). [PMID: 39250117](https://pubmed.ncbi.nlm.nih.gov/39250117/). *Invest Ophthalmol Vis Sci*. [Basic Science / Preclinical]